What Is (S)-scoulerine 9-O-methyltransferase
Content on WhatAnswers is provided "as is" for informational purposes. While we strive for accuracy, we make no guarantees. Content is AI-assisted and should not be used as professional advice.
Last updated: April 10, 2026
Key Facts
- Officially classified as EC 2.1.1.117 in the enzyme commission system for O-methyltransferases
- Molecular weight of 63,000 Da with pH optimum of 8.9 and high substrate specificity
- Catalyzes methylation at the 9-position of scoulerine to form tetrahydrocolumbamine intermediate
- Uses S-adenosyl methionine (SAM) as the methyl donor in benzylisoquinoline alkaloid pathways
- Recent structure-guided engineering (2019) enabled successful heterologous production in Saccharomyces cerevisiae yeast
Overview
(S)-scoulerine 9-O-methyltransferase is a highly specialized enzyme classified as EC 2.1.1.117 that catalyzes a crucial methylation reaction in alkaloid biosynthesis. The enzyme transfers a methyl group from S-adenosyl methionine (SAM) to the hydroxyl group at position 9 of (S)-scoulerine, producing (S)-tetrahydrocolumbamine. This transformation represents a pivotal step in the biosynthetic pathways that generate benzylisoquinoline alkaloids (BIAs), a diverse class of plant natural products with significant pharmaceutical potential.
This methyltransferase is found in medicinal plants including Coptis japonica, Thalictrum species, and Papaver species. The enzyme has been extensively studied due to its role in producing berberine, palmatine, and other alkaloids used in traditional and modern medicine. With a molecular weight of approximately 63 kilodaltons and a pH optimum of 8.9, the enzyme demonstrates exceptional catalytic efficiency and substrate selectivity in plant secondary metabolism.
How It Works
The enzyme functions through a well-characterized methylation mechanism that requires specific substrate orientation and cofactor binding:
- Substrate Recognition: The enzyme specifically recognizes (S)-scoulerine through multiple binding interactions, ensuring high stereochemical selectivity and preventing unwanted methylation of non-target compounds.
- Methyl Transfer Mechanism: S-adenosyl methionine serves as the universal methyl donor in nature, transferring its methyl group (CH₃) to the hydroxyl oxygen at position 9 of scoulerine through an SN2-type nucleophilic displacement reaction.
- Product Formation: The reaction yields (S)-tetrahydrocolumbamine as the primary product while releasing S-adenosylhomocysteine (SAH), which is recycled in cellular methylation pathways.
- Cofactor Dependency: The enzyme requires no prosthetic groups or metal cofactors, operating solely through protein-mediated catalysis of the methyl transfer from SAM to the substrate hydroxyl group.
- Non-Particulate Nature: Unlike some methyltransferases bound to cellular membranes, this enzyme exists as a soluble, cytoplasmic protein enabling direct interaction with diffusible substrates.
Key Comparisons
| Property | (S)-Scoulerine 9-O-MTase | General O-Methyltransferases | N-Methyltransferases |
|---|---|---|---|
| Substrate Type | Hydroxyl groups on benzylisoquolines | Diverse hydroxyl-containing substrates | Amino groups and amines |
| Molecular Weight | ~63 kDa | 30-100 kDa range | 20-80 kDa range |
| pH Optimum | 8.9 (alkaline) | 6.5-8.5 (neutral to slightly alkaline) | 7.0-8.0 (neutral) |
| Substrate Specificity | Highly specific (S-scoulerine only) | Moderate to broad specificity | Moderate specificity |
| Primary Role | Alkaloid biosynthesis intermediates | Diverse methylation reactions | Alkaloid and amine metabolism |
Why It Matters
Pharmaceutical Production: This enzyme catalyzes essential steps in synthesizing berberine and palmatine—alkaloids with documented antibacterial, antiproliferative, and neuroprotective properties. By understanding enzyme mechanisms, researchers can optimize production of these compounds in medicinal plants or through biotechnological platforms.
Biotechnological Applications: Recent advances in enzyme engineering (2019) have enabled heterologous expression of optimized scoulerine methyltransferase variants in baker's yeast (Saccharomyces cerevisiae). This breakthrough allows microbial fermentation to produce pharmaceutical alkaloids more efficiently than traditional plant extraction.
Synthetic Biology: The enzyme is a key component in reconstituted alkaloid biosynthetic pathways within cell-free systems and engineered microorganisms. Structure-guided engineering has created enzyme variants capable of accepting non-natural substrates, enabling synthesis of previously inaccessible alkaloid derivatives.
Medical Research Impact: Benzylisoquinoline alkaloids produced via this enzymatic pathway demonstrate anti-inflammatory, antitumor, and antioxidant activities. Reliable production methods facilitate clinical research into alkaloid-based therapeutics for conditions including bacterial infections, cancer, and neurodegenerative diseases.
The enzyme's high stereochemical specificity and regiocontrol make it an invaluable catalyst in natural product chemistry. As synthetic biology and fermentation technologies advance, engineered versions of (S)-scoulerine 9-O-methyltransferase will likely become central to sustainable production of complex plant alkaloids for pharmaceutical development.
More What Is in Daily Life
Also in Daily Life
More "What Is" Questions
Trending on WhatAnswers
Browse by Topic
Browse by Question Type
Sources
- Wikipedia: (S)-scoulerine 9-O-methyltransferaseCC-BY-SA-4.0
- BRENDA Enzyme Database: EC 2.1.1.117CC-BY-4.0
- ACS Catalysis: Structure-Guided Engineering of Scoulerine 9-O-MethyltransferaseACS Publications
- Plant Cell Reports: S-adenosyl-L-methionine Scoulerine 9-O-methyltransferaseSpringer
- Frontiers: Advances in Benzylisoquinoline Alkaloid BiosynthesisCC-BY-4.0
Missing an answer?
Suggest a question and we'll generate an answer for it.